Corifollitropin alfa 在长效 GnRH 激动剂方案中的应用：概念验证试验。
Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial.
机构信息
Center for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.
出版信息
Fertil Steril. 2010 Oct;94(5):1922-4. doi: 10.1016/j.fertnstert.2009.12.070. Epub 2010 Feb 10.
Abstract
Fifty healthy women, aged 18-39 years with no known risk of ovarian hyperstimulation were treated with 100 or 150 μg corifollitropin alfa (dependent on body weight) in a long GnRH agonist protocol. At these doses, corifollitropin alfa initiated and supported growth of a large cohort of follicles during the first week of ovarian stimulation.
摘要
50 名 18-39 岁的健康女性，无卵巢过度刺激综合征的已知风险，根据体重接受 100 或 150μg 戈那瑞林的长 GnRH 激动剂方案治疗。在这些剂量下，戈那瑞林在卵巢刺激的第一周启动并支持了大量卵泡的生长。
Zotero 插件